. " " . (BTW) Ernst & Young . Ernst & Young . 23 14 . . Reise vor9 . : 8.8 . 20 - 713 . " ". ./. <ul><li></li><li> .. 2022 80 (07.01.2022) . </li><li></li><li></li><li></li>… [+40 chars]
« » 10 . « » . 1700 «» 1994 . 51 75 68 % . . 10 . . 20.5 % . 51-55 5 % 37 % 66 70 % 71-75 . 7 123 (7 %) : 17.5 % 4.5 %. 10 84 % . . 38 % 13 % .
() () . . " " (The Central European Journal of Urology) . "" (erectile dysfunction). (Visceral fat) . " ". " " (Eat This, Not That) . . . . : . . " " (The Journal of Nutrition) . … [+309 chars]
« » 10 . « » . 1700 «» 1994 . 51 75 68 % . . 10 . . 20.5 % . 51-55 5 % 37 % 66 70 % 71-75 . 7 123 (7 %) : 17.5 % 4.5 %. 10 84 % . . 38 % 13 % .
. " " . (BTW) Ernst & Young . Ernst & Young . 23 14 . . Reise vor9 . : 8.8 . 20 - 713 . " ". ./. <ul><li></li><li> .. 2022 80 (07.01.2022) . </li><li></li><li></li><li></li>… [+40 chars]
"Nature" . "Neuroscience News" . : " ". " () ". -: " ". " ." . Lac-Phe. "" . Lac-Phe 50 12 . 10 Lac-Phe ( ) . CNDP2 CNDP2 Lac-Phe . Lac-Phe . Lac-Phe . : " ( ) Lac-Phe " " ".
, 26/06/2022 - 10:33
Your job has been successfully posted. Your story has been successfully deleted. Your message has been sent, we will get back to you soon. Your profile has been updated. Your story has been succe… [+774 chars]
. . " " (WebMD) . . : 20 35 . . . () . . 1500 2300 . " " (Healthline) 900 (2300 ) 38% . . . (MSG) . . "" "". . . . "" . " -3" (3-MCPD) . . . . - - . () . … [+10 chars]
Your job has been successfully posted. Your story has been successfully deleted. Your message has been sent, we will get back to you soon. Your profile has been updated. Your story has been succe… [+774 chars]
. : - : . . - : . ( ). - : . : . . : . 2. ATR-258 . . ATR-258 Atrogi . - - . ATR-258 - . 80 CRS Clinical Research Services . : « 2 ». ». ATR-258 .
. : - : . . - : . ( ). - : . : . . : . 2. ATR-258 . . ATR-258 Atrogi . - - . ATR-258 - . 80 CRS Clinical Research Services . : « 2 ». ». ATR-258 .
